Smartphone Mobile App and Remote Programme in Behavioural, Diet and Lifestyle Interventions for Prevention and Management of Early Diabetes and Pre-Diabetes. (D'LITE Study - Diabetes Lifestyle Intervention using Technology Empowerment)
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 352
研究概览
简要总结
Among the individuals with diabetes, the mHealth group achieved significantly greater weight loss and blood glucose control, with a greater proportion of diabetes medications reduction, as compared to the standard care group. With the prediabetes group, the weight achieved by the mHealth group was also significantly greater than the control group. There was a 4.3 fold increased likelihood of achieving 5% weight loss, and 2.1 higher likelihood of achieving normoglycemia, as compared to the control group. The median overall app engagement rate was maintained at 90% at 6 months. Among the mHealth group, participants who were more engaged were associated with the greatest overall weight reduction of 10.6% at 6 months, and greater HbA1c reduction of up to 1.2%, as compared to those who were disengaged from the app.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Prevention
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 21 Years 至 75 Years（—）
- 性别
- All
入选标准
- •Participants will be eligible for the study if they meet the following criteria:
- •- Adults between 21 to 75 years old identified during community health screening or by doctors as having pre-diabetes (FBG = 6.1 - 6.9 mmol/L or Impaired Glucose Tolerance) or Type 2 diabetes (FBG equal or greater than 7.0 mmol/L or known diabetes based on OGTT)
- •- Body Mass Index (BMI) of 23 kg/m2 or higher
- •- Owns a smartphone with data plan
- •- English speaking
排除标准
- •Participants will be excluded if they have:
- •- known severe cognitive or psychological disabilities
- •- heart failure
- •- stage 4 and above kidney disease
- •- untreated hypothyroidism
- •- depression
- •- Type 1 Diabetes
- •- pregnant
- •- non-resident
- •- not keen to participate
- •- Type 2 Diabetes on insulin
- •- non-compliance to diabetic medications
- •- untreated anemia, thalassemia or other blood disorder
- •- have hbA1c readings that do not correspond to the other blood glucose measurements, as clinically assessed by the investigators.